Arcus Biosciences, Inc. (RCUS)

29.76 -0.09 (-0.30%) USD  |  NYSE  |  Sep 03, 15:44
More

Arcus Biosciences Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for RCUS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Total Expenses (% of Annual Revenues) Data

View and export this data back to 2017. Start Trial.
Date Value
December 31, 2025 --
December 31, 2024 --
December 31, 2023 --
December 31, 2022 --
December 31, 2021 --
Date Value
December 31, 2020 --
December 31, 2019 --
December 31, 2018 --
December 31, 2017 --

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Halozyme Therapeutics, Inc. Upgrade
AVITA Medical, Inc. Upgrade
Iovance Biotherapeutics, Inc. Upgrade
Editas Medicine, Inc. Upgrade
Recursion Pharmaceuticals, Inc. Upgrade